RE: Away from the first option12 May 2025 10:52
The Company experienced renewed demand for the X-PLOR during April, resulting in a record sales month of $0.52m. Demand for the X-PLOR remains robust, reflecting the growing need for portable oxygen solutions globally.
the Company has initiated a strategic review, which will evaluate a range of options to substantially strengthen its capital position, including potential strategic investment, partnerships, alternative funding structures and other corporate initiatives.